Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Jan 10

PMID 35003112

Authors

Zhen-Dong Huang

Zi-Zhen Liu

Yan-Yi Liu

Yong-Cheng Fu

Lu-Lu Lin

Chao Hu

Hui-Yun Gu

Ren-Xiong Wei

Affiliations

Soon will be listed here.

Abstract

Objective: Head and neck squamous cell carcinoma (HNSCC) is one of the most common and lethal malignant tumors. We aimed to investigate the HNSCC cell differentiation trajectories and the corresponding clinical relevance.

Methods: Based on HNSCC cell differentiation-related genes (HDRGs) identified by single-cell sequencing analysis, the molecular subtypes and corresponding immunity, metabolism, and stemness characteristics of 866 HNSCC cases were comprehensively analyzed. Machine-learning strategies were used to develop a HNSCC cell differentiation score (HCDscore) in order to quantify the unique heterogeneity of individual samples. We also assessed the prognostic value and biological characteristics of HCDscore using the multi-omics data.

Results: HNSCCs were stratified into three distinct molecular subtypes based on HDRGs: active stroma (Cluster-A), active metabolism (Cluster-B), and active immune (Cluster-C) types. The three molecular subtypes had different characteristics in terms of biological phenotype, genome and epigenetics, prognosis, immunotherapy and chemotherapy responses. We then demonstrated the correlations between HCDscore and the immune microenvironment, subtypes, carcinogenic biological processes, genetic variation, and prognosis. The low-HCDscore group was characterized by activation of immunity, enhanced response to anti-PD-1/PD-L1 immunotherapy, and better survival compared to the high-HCDscore group. Finally, by integrating the HCDscore with prognostic clinicopathological characteristics, a nomogram with strong predictive performance and high accuracy was constructed.

Conclusions: This study revealed that the cell differentiation trajectories in HNSCC played a nonnegligible role in patient prognosis, biological characteristics, and immune responses. Evaluating cancer cell differentiation will help to develop more effective immunotherapy, metabolic therapy, and chemotherapy strategies.

Citing Articles

Unravelling the Complexity of HNSCC Using Single-Cell Transcriptomics.

Conde-Lopez C, Marripati D, Elkabets M, Hess J, Kurth I Cancers (Basel). 2024; 16(19).

PMID: 39409886 PMC: 11475296. DOI: 10.3390/cancers16193265.

Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.

Huang M, Cha Z, Liu R, Lin M, Gafoor N, Kong T Front Immunol. 2024; 15:1399926.

PMID: 38817608 PMC: 11137211. DOI: 10.3389/fimmu.2024.1399926.

Application of single-cell RNA sequencing in head and neck squamous cell carcinoma.

An Z, Liu W, Li W, Wei M, An C Chin J Cancer Res. 2023; 35(4):331-342.

PMID: 37691894 PMC: 10485914. DOI: 10.21147/j.issn.1000-9604.2023.04.01.

Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients.

Chi H, Peng G, Wang R, Yang F, Xie X, Zhang J Cells. 2022; 11(21).

PMID: 36359832 PMC: 9658590. DOI: 10.3390/cells11213436.

Automated Nuclear Segmentation in Head and Neck Squamous Cell Carcinoma Pathology Reveals Relationships between Cytometric Features and ESTIMATE Stromal and Immune Scores.

Blocker S, Cook J, Everitt J, Austin W, Watts T, Mowery Y Am J Pathol. 2022; 192(9):1305-1320.

PMID: 35718057 PMC: 9484476. DOI: 10.1016/j.ajpath.2022.06.003.

References

Aran D, Looney A, Liu L, Wu E, Fong V, Hsu A . Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019; 20(2):163-172. PMC: 6340744. DOI: 10.1038/s41590-018-0276-y. View

Chen T, Hsieh Y, Huang J, Liu C, Chuang L, Huang P . Determination of Pyruvate Metabolic Fates Modulates Head and Neck Tumorigenesis. Neoplasia. 2019; 21(7):641-652. PMC: 6522776. DOI: 10.1016/j.neo.2019.04.007. View

Yang J, Guo Y, Seo W, Zhang R, Lu C, Wang Y . Targeting cellular metabolism to reduce head and neck cancer growth. Sci Rep. 2019; 9(1):4995. PMC: 6428890. DOI: 10.1038/s41598-019-41523-4. View

Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

Huang Z, Yao Y, Chen T, Zhao Y, Zhang C, Niu Y . Construction of Prognostic Risk Prediction Model of Oral Squamous Cell Carcinoma Based on Nine Survival-Associated Metabolic Genes. Front Physiol. 2021; 12:609770. PMC: 8011568. DOI: 10.3389/fphys.2021.609770. View

Butler A, Hoffman P, Smibert P, Papalexi E, Satija R . Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018; 36(5):411-420. PMC: 6700744. DOI: 10.1038/nbt.4096. View

Aran D, Hu Z, Butte A . xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017; 18(1):220. PMC: 5688663. DOI: 10.1186/s13059-017-1349-1. View

Malta T, Sokolov A, Gentles A, Burzykowski T, Poisson L, Weinstein J . Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell. 2018; 173(2):338-354.e15. PMC: 5902191. DOI: 10.1016/j.cell.2018.03.034. View

Newman A, Steen C, Liu C, Gentles A, Chaudhuri A, Scherer F . Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019; 37(7):773-782. PMC: 6610714. DOI: 10.1038/s41587-019-0114-2. View

10.

Mariathasan S, Turley S, Nickles D, Castiglioni A, Yuen K, Wang Y . TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018; 554(7693):544-548. PMC: 6028240. DOI: 10.1038/nature25501. View

11.

Fang R, Iqbal M, Chen L, Liao J, Luo J, Wei F . A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. Aging (Albany NY). 2021; 13(8):11507-11527. PMC: 8109104. DOI: 10.18632/aging.202842. View

12.

Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman D . IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017; 127(8):2930-2940. PMC: 5531419. DOI: 10.1172/JCI91190. View

13.

Mayakonda A, Lin D, Assenov Y, Plass C, Koeffler H . Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018; 28(11):1747-1756. PMC: 6211645. DOI: 10.1101/gr.239244.118. View

14.

Wilkerson M, Hayes D . ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010; 26(12):1572-3. PMC: 2881355. DOI: 10.1093/bioinformatics/btq170. View

15.

Qi Z, Barrett T, Parikh A, Tirosh I, Puram S . Single-cell sequencing and its applications in head and neck cancer. Oral Oncol. 2019; 99:104441. PMC: 6981283. DOI: 10.1016/j.oraloncology.2019.104441. View

16.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

17.

Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H . Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019; 11(1):34. PMC: 6534875. DOI: 10.1186/s13073-019-0638-6. View

18.

Idel C, Ribbat-Idel J, Klapper L, Krupar R, Bruchhage K, Dreyer E . Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas. Front Oncol. 2021; 11:712788. PMC: 8581660. DOI: 10.3389/fonc.2021.712788. View

19.

Zhang L, Li B, Peng Y, Wu F, Li Q, Lin Z . The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study. Oral Oncol. 2020; 110:104943. DOI: 10.1016/j.oraloncology.2020.104943. View

20.

Racle J, Gfeller D . EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data. Methods Mol Biol. 2020; 2120:233-248. DOI: 10.1007/978-1-0716-0327-7_17. View